logo
logo
Sign in

Precision Medicine Market Is Estimated To Witness High Growth Owing To Increasing Demand for Personalized Treatment

avatar
Sachin Sadgir
Precision Medicine Market Is Estimated To Witness High Growth Owing To Increasing Demand for Personalized Treatment

The global Precision Medicine Market is estimated to be valued at US$ 73,946.2 Million In 2022 and is expected to exhibit a CAGR of 10.3% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Precision medicine refers to a medical model that tailors healthcare decisions and interventions to individual patients based on their genetic, environmental, and lifestyle factors. It involves the use of advanced technologies, such as genetic sequencing and molecular diagnostics, to develop targeted therapies for specific individuals. The precision medicine market offers several advantages, including improved treatment outcomes, reduced side effects, and minimized healthcare costs. The need for personalized treatments has emerged due to the increasing prevalence of chronic diseases, rising healthcare expenditure, and advancements in genomic research.

Market Key Trends:

One key trend in the precision medicine market is the increasing focus on genomic medicine. Genomic medicine involves the analysis of a patient's genetic information to understand their individual risks for certain diseases and to develop targeted therapies. Advances in genomic sequencing technologies, decreasing costs of genetic testing, and the availability of large-scale genomic databases have fueled the adoption of genomic medicine in precision medicine. Genomic medicine enables healthcare providers to identify genetic markers that can be used to predict disease risk, personalize treatment options, and improve patient outcomes.

PEST Analysis

Political: In the global Precision Medicine Market, political factors can play a significant role in shaping the industry's growth. Government regulations and policies regarding healthcare, pharmaceuticals, and biotechnology can impact the adoption and development of precision medicine. For example, changes in regulatory frameworks that promote personalized medicine and facilitate the approval process for novel therapeutics can drive market growth.

Economic: The economic factors influencing the precision medicine market include factors such as healthcare spending, GDP growth, and per capita income. Economic conditions can impact the affordability and accessibility of precision medicine technologies and treatments. Increasing healthcare expenditure, particularly in emerging economies, and the growing disposable income of individuals can contribute to the market's expansion.

Social: Social factors encompass societal attitudes, demographics, and lifestyle choices that can shape the demand for precision medicine. Factors such as aging population, rising prevalence of chronic diseases, and increasing awareness about personalized medicine and its benefits can drive the adoption of precision medicine solutions.

Technological: Technological advancements have a significant impact on the precision medicine market. Innovations in genomics, molecular diagnostics, and data analytics have transformed the field by enabling more accurate diagnostics, targeted therapies, and personalized treatment plans. Moreover, the integration of artificial intelligence (AI) and machine learning in precision medicine has the potential to revolutionize disease management and treatment.

Key Takeaways

The global precision medicine market is expected to witness high growth, exhibiting a CAGR of 10.3% over the forecast period. This growth can be attributed to several factors, including the increasing prevalence of chronic diseases, advancements in genetics and molecular diagnostics, and the shift towards personalized medicine.

In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the precision medicine market. The presence of well-established healthcare infrastructure, favorable government initiatives, and significant investments in research and development contribute to the region's growth. Additionally, the active participation of key players in this region further stimulates market expansion.

Key players operating in the precision medicine market include Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMérieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics, Inc., Bristol-Myers Squibb Company, and Found. These key players play a crucial role in driving innovation, research, and development in the precision medicine field, contributing to the market's growth.

Read More : https://www.ukwebwire.com/2079-2/

collect
0
avatar
Sachin Sadgir
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more